Patrice Talaga

Discovery of 4-Substituted Pyrrolidone Butanamides as New Agents with Significant Antiepileptic Activity

Benoît Kenda, Alain Matagne, Patrice Talaga et al. · Journal of Medicinal Chemistry · 2003 · 222 citations · Full text

New Agents, Drug Target, Pharmaceutical Science +18

SV2A protein is a broad-spectrum anticonvulsant target: Functional correlation between protein binding and seizure protection in models of both partial and generalized epilepsy

Rafał M. Kamiński, Alain Matagne, Karine Leclercq et al. · Neuropharmacology · 2007 · 166 citations

Generalized Epilepsy, Neurophysiology, Seizure Protection +5

Patch testing with the “sesquiterpene lactone mix”: a marker for contact allergy to Compositae and other sesquiterpene‐lactone‐containing plants <i>A multicentre study of the EECDRG</i>

G. Ducombs, Claude Benezra, Patrice Talaga et al. · Contact Dermatitis · 1990 · 96 citations

First dual NK1 antagonists–serotonin reuptake inhibitors: synthesis and SAR of a new class of potential antidepressants

Thomas Ryckmans, Laurent Balançon, Olivier Berton et al. · Bioorganic & Medicinal Chemistry Letters · 2002 · 69 citations · Full text

Functional Selectivity, Medicine, Psychotropic Medication +6

Identification of 4-(1<i>H</i>-Imidazol-4(5)-ylmethyl)pyridine (Immethridine) as a Novel, Potent, and Highly Selective Histamine H₃Receptor Agonist

Ruengwit Kitbunnadaj, Obbe P. Zuiderveld, B. Christophe et al. · Journal of Medicinal Chemistry · 2004 · 61 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Allergy +14